Systems and methods for scalable manufacturing of therapeutic cells in bioreactors
AssigneePBS Biotech, Inc.
InventorsChanyong Brian Lee, Breanna Shalyn Borys
Life of this patent
Estimating the term…
Loading patent…
AssigneePBS Biotech, Inc.
InventorsChanyong Brian Lee, Breanna Shalyn Borys
Estimating the term…
Systems and methods for scalable manufacturing of therapeutic cells in bioreactors are disclosed. Fluid dynamic considerations for scale in accordance with an implementation include a method of production of therapeutic cells grown on microcarriers or as cell aggregates in a suspension-based bioreactor includes depositing a suspension comprising cells suspended in a volume of culture fluid into a bioreactor and setting an agitation rate of a mixer disposed in the bioreactor. The method includes actuating the mixer at the set agitation rate to mix the suspension in the bioreactor. The suspension includes a plurality of turbulent eddies generated by the mixer. A magnitude of an energy dissipation rate (EDR) of at least approximately 60% of the turbulent eddies can be less than approximately 0.0015 m2/s3.
A method of scaling production of therapeutic cells grown on microcarriers or as cell aggregates in a suspension-based bioreactor, the method comprising:
A method of operating a large scale suspension-based bioreactor for the production of cells grown on microcarriers or as cell aggregates, the method comprising:
A large scale suspension-based system for the production of cells grown on microcarriers or as cell aggregates, the system comprising:
Method of production of therapeutic cells grown on microcarriers or as cell aggregates in a suspension-based bioreactor, the method comprising:
41-54. (canceled)
Dependencies are inferred from the claim text.